We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Bsf Enterprise Plc | LSE:BSFA | London | Ordinary Share | GB00BHNBDQ51 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.25 | 5.26% | 5.00 | 4.50 | 5.50 | 5.00 | 4.75 | 4.75 | 102,489 | 09:22:28 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Finance Services | 13k | -1.5M | -0.0145 | -3.45 | 5.17M |
Date | Subject | Author | Discuss |
---|---|---|---|
20/3/2024 11:08 | Another Burton Banger. 5p? | shortcpx | |
13/3/2024 08:42 | Looking for a Company focused on the next generation of biotech solutions to transform the delivery of sustainable outcomes? Then think BSF Enterprise suggest @TMSreach "...But BSFA's fundamental case remains strong: here is a UK-based pioneer of technologies capable of breaking into vast markets..." https://total-market | burtond1 | |
07/3/2024 14:48 | The tie up with Ivy Farms to tap into the Chinese market looks like a very shrewd move to me. I'm sure the they will have Chinese investors lined up to fund growth | trotterstrading | |
22/2/2024 07:32 | Eye can see a bump today. | babbler | |
19/2/2024 17:21 | This will trade under 1p by the end of the year. Do NOT trust McNumpty | denholm elliott | |
16/2/2024 14:47 | https://x.com/bsf_en | jailbird | |
16/2/2024 14:44 | WTFSo they are reading the Quran when growing the meat ? Do they expect us to believe that !!BSF Enterprise welcomes the advancement in halal certification for lab-grown meat, underlining our role in pioneering responsible and inclusive food technologies. thetak | jailbird | |
10/2/2024 11:56 | Analysis completed. Looks like circa 5p is the first support level here. WARNING! McNulty is ramping on twitter, so if his usual MO is employed he'll be dumping into your buys. DYOR | the imperialist | |
31/1/2024 08:20 | In summary, nothing money making has happened. | simonsmithiv | |
31/1/2024 08:19 | Cash runway to March 2025 says in the results | trotterstrading | |
31/1/2024 08:17 | Cash hungry company years away from generating any regular revenue until that happens be prepared for discounted placings | hamidahamida | |
30/11/2023 15:52 | MM has 19.5k followers on X (twtr)for good reason. He'll be the first to admit he doesn't always get it right but, on the whole, he's a pretty good stock picker. | walter walcarpets | |
30/11/2023 15:11 | Well, that is an interesting RNS just out. Money where the mouth is from Myles McNulty. The 3% threshold crossed to disclose a 3.19% holding. Go on there! Going for gold! A few more stake builders and it could have some legs this. I'm just watching from the sidelines though. All imo DYOR | sphere25 | |
28/11/2023 15:45 | Walter Walcarpets, It's a continued tough market. Hard to keep hitting the trades in this market. I try but exit quick if they go flat or look weak - loving to take little losses works in the long run. Some pop now and again, which is nice, but it's still a grind until sentiment and flows change. As for these high riskers like FAB, we can never be sure which ones are going to attract anomalous buying like that. FAB didn't even move for most of the morning too and has now traded about 34% of the share issuance - without delayed prints! That is blooming bonkers! How often do we see that nowadays? But it provides enough demand for alot to benefit and overcome those sellers in size, rather than the usual little pop up and back down. Well good luck with the trading. We're all in the same choppy watered boat until better times come. All imo DYOR | sphere25 | |
28/11/2023 14:28 | Cheers Sphere25. Sadly, no. Bought in at 7p and missed this morning's rise. If only I knew what I was doing :-)) | walter walcarpets | |
28/11/2023 14:06 | Didn't spot FAB. Just had a quick look. 59,453,714 shares in issue and blowout exchanges of 13.4m right now, so yes point in case, whopping big buying gives the price a chance to clear those monster sellers for some momentum. Plenty of traders done well there. They can lob into the spike. Well done if you have too. All imo DYOR | sphere25 | |
28/11/2023 13:56 | Just have a look at FAB to see what can happen. | walter walcarpets | |
28/11/2023 13:50 | Had a go here last November (15th November 2022 Post 37) on the major news that day. It worked out well for a trade, but a year on, still sat here wondering the same thing: "When you look at these announcements, you sit and wonder just how far these things could go and how big they could eventually get. The problem is it is Penny Punt Land, where the reality is a minority making it really big, and losses for the near majority eventually coming to the fore. Clearly these moments of excitement can provide profitable short term opportunities too" Looking around the market, it has just been a systematic annihilation of the majority of these sorts of penny punt/highly speculative shares. The forums are almost a testament to that, being graveyard like. It won't stop in this normalised higher rate environment - the market will continue on its brutal streak of cleansing. The update from BSFA on Friday was interesting. Major names in the mix here from the update. In a different market a highly speculative share like this goes screaming north on that update alone. In this market it is almost the theme now that a positive new release will result in limited movement higher or a quick sell back down. It goes like this: --> Positive news release --> Market makers mark the price up --> A little surge in buying that fizzles out --> Big sellers sat in the background sell into the little spike to overwhelm the buyers and kill off any momentum --> Price ends up stalling and then coming back down Watched a fair few of these, and it is almost pointless having a go, unless there is blowout buying coming in. I suspect BSFA will need at least a double digit millions day to have a chance of real momentum. I can see a little pop today with just over 2m shares trade. Myles Mcnulty along with others on X clearly have influence. Interestingly, right now they have more influence than the likes of Simon Thompson of IC, Robbie Burns (Naked Trader) and even SCSW where there is very little influence nowadays, sometimes just the odd few buys with the old guard tipsters/commentator Barring some real game changing announcement here (and elsewhere) in these highly speculative shares, I don't see how the market will change its view on them. The market will constantly look more at the need for funding (than the bullish updates) and the price will just drift expecting another placing. If you have 18 months of cash, in 6 months time the market is looking even more strongly toward the financing side, so the bullish news has to be transformational, or market sentiment has to change in a material way. That said, this is one of the few that did catch the eye last year and still looks interesting. It might be a 10/90 against sort of play, but it stays on the watchlist to see if any big buying does eventually come in. In the graveyard of hundreds, there are still the odd few that can make it big. Wonder if this is one of them. Maybe come back in another year to comment :-) All imo DYOR | sphere25 | |
28/11/2023 09:30 | Myles Mcnulty: | walter walcarpets | |
24/11/2023 09:12 | It's like Harry Potter this share, always one of the "largest companies in the world" blah blah that shall not be named! | simonsmithiv | |
24/11/2023 07:55 | RNS Number : 5345U BSF Enterprise PLC 24 November 2023 24 November 2023 BSF Enterprise PLC ("BSF" or the "Company") 3D Bio-Tissues Product Partnership Progress BSF (LSE: BSFA), (OTCQB: BSFAF), the Main Market listed biotech company and owner of pioneering UK-based clinical and cellular agriculture company 3D Bio-Tissues (3DBT), provides an update on the Company's partnership progress across several of 3DBT's product verticals. Etsyl (TM) Commercial Update 3DBT is pleased to announce that it has entered into a proof-of-concept contractual agreement with one of the largest cosmetic companies in the world, which will test the suitability of the Company's proprietary lipopeptide product, Etsyl(TM), for use within its skin cream cosmetic solutions. 3DBT is harnessing the natural regenerative ability of human skin cells to drive rapid tissue regeneration and repair. Its Etsyl(TM) promotes cellular collagen production in human skin cells, with cosmetic and pharmacological applications as a bioactive ingredient in skincare formulations for the fabrication of native-like skin substitutes for clinical, cosmetic and industrial applications. The cosmetic company which BSF is working with specialises in the research and development of bioactive ingredients for skin care which, with proven efficacy, can aid in anti-ageing, moisturising and acne control. EIT Grant In September 2023, 3D Bio-Tissues announced that it has been awarded a EUR612,000 grant from the European Institute of Innovation and Technology ("EIT Food") to upscale the production and sales of its proprietary serum-free media, City-Mix(TM). City-Mix(TM) is an animal-free cell growth agent for culturing skin, muscle and fat cells for use in cultivated meat and leather production. Further to this, 3DBT is pleased to announce that it now has two new staff members in place to focus on securing additional procurement, manufacturing and distribution partnerships in the food-tech and biotech sectors, including Mr Adam Crosby, an operational manager with broad-level experience across multiple industries, and a successful track record in delivering multi-million-pound projects and facilitating growth. The Company has also hired an experienced Technical Sales Specialist to strengthen its sales team. Book launch Chief Executive of 3DBT, Professor Che Connon, has co-authored a book entitled Advances in Cultured Meat Technology, that explores the potential of cultured meat production in solving food security. Publication of the book is expected to further enhance Professor Connon, and the Company's international profile and reputation within the rapidly advancing cultured meat industry. Che Connon, Chief Executive of 3DBT and Managing Director of BSF said: "We are delighted to be working with one of the world's largest cosmetic companies, which highlights the potential of our Etsyl product and the diverse applications of our technology. Furthermore, with an enlarged team in hand, we hope to secure further partnerships and sales for our various product offerings at an accelerated pace, and we look to the future with confidence." For further enquiries, pleas | walter walcarpets |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions